Empagliflozin (SGLT-2 Inhibitor) Ameliorates Early Features of Diabetic Retinopathy and Nephropathy in Type 2 Diabetic Mice Model via the Klotho Protein: PO0716

Empagliflozin (SGLT-2 Inhibitor) Ameliorates Early Features of Diabetic Retinopathy and Nephropathy in Type 2 Diabetic Mice Model via the Klotho Protein PO0716

Saved in:
Bibliographic Details
Published in:Journal of the American Society of Nephrology Vol. 32; no. 10S; p. 254
Main Authors: Nakhoul, Farid M., Ertracht, Offir, Nakhoul, Nakhoul, Farber, Evgeny, Tadmor, Hagar, Saad, Ranin, Atar, Shaul, Igbariye, Anas
Format: Journal Article
Language:English
Published: 01-10-2021
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:1046-6673
DOI:10.1681/ASN.20213210S1254d